| 臺大學術典藏 |
2021-10-04T07:15:50Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:50Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-10-04T07:15:34Z |
Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination
|
Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHANG KO; Chou Y.-T. |
| 臺大學術典藏 |
2021-09-01T01:54:05Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; Chang M.-C.; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; ANN-LII CHENG; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
| 臺大學術典藏 |
2021-07-28T09:53:19Z |
Cwc25 is a novel splicing factor required after Prp2 and Yju2 to facilitate the first catalytic reaction
|
Chiu Y.-F; | Liu Y.-C; | Chiang T.-W; | Yeh T.-C; | CHI-KANG TSENG; | Wu N.-Y; | Cheng S.-C. |
| 臺大學術典藏 |
2021-04-29T05:09:10Z |
Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia
|
Hosgood III H.D.; Wang W.-C.; Hong Y.-C.; Wang J.-C.; Chen K.; Chang I.-S.; Chen C.-J.; Lu D.; Yin Z.; Wu C.; Zheng W.; Qian B.; Park J.Y.; Kim Y.H.; Chatterjee N.; Chen Y.; Chang G.-C.; Hsiao C.-F.; Yeager M.; Tsai Y.-H.; Wei H.; Kim Y.T.; Wu W.; Zhao Z.; Chow W.-H.; Zhu X.; Lo Y.-L.; Sung S.W.; KUAN-YU CHEN; Yuenger J.; Kim J.H.; Huang L.; Chen Y.-H.; Gao Y.-T.; Kim J.H.; Huang M.-S.; Jung T.H.; Caporaso N.; Zhao X.; Huan Z.; Yu D.; Kim C.H.; Su W.-C.; Shu X.-O.; Kim I.-S.; Bassig B.; Chen Y.-M.; Cha S.I.; Tan W.; Chen H.; Yang T.-Y.; Sung J.S.; Wang C.-L.; Li X.; Park K.H.; Yu C.-J.; Ryu J.-S.; Xiang Y.; Hutchinson A.; Kim J.S.; Cai Q.; Landi M.T.; Lee K.-M.; Hung J.-Y.; Park J.-Y.; Tucker M.; Lin C.-C.; Ren Y.; Perng R.-P.; Chen C.-Y.; Jin L.; Chen K.-C.; Li Y.-J.; Chiu Y.-F.; Tsai F.-Y.; Yang P.-C.; Fraumeni Jr. J.F.; Seow A.; Lin D.; Zhou B.; Chanock S.; Hsiung C.A.; Rothman N.; Lan Q. |
| 臺大學術典藏 |
2021-03-11T08:34:28Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
Jen-Chang Ko ;Tsai M.-S. ;Kuo Y.-H. ;Chiu Y.-F. ;Weng S.-H. ;Su Y.-C. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:28Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:27Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
Jen-Chang Ko;Tsai M.-S.;Weng S.-H.;Kuo Y.-H.;Chiu Y.-F.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:27Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
Jen-Chang Ko;Tsai M.-S.;Chiu Y.-F.;Weng S.-H.;Kuo Y.-H.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:34:15Z |
Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination
|
Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHANG KO; Chou Y.-T. |
| 臺大學術典藏 |
2021-03-11T08:29:41Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:40Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Weng S.-H. ;Kuo Y.-H. ;Chiu Y.-F. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:40Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Chiu Y.-F. ;Weng S.-H. ;Kuo Y.-H. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:40Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
Jen-Chang Ko ;Tsai M.-S. ;Kuo Y.-H. ;Chiu Y.-F. ;Weng S.-H. ;Su Y.-C. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T08:29:29Z |
Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination
|
Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHANG KO; Chou Y.-T. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Modulation of Rad51, ERCC1, and thymidine phosphorylase by emodin result in synergistic cytotoxic effect in combination with capecitabine
|
Jen-Chang Ko;Tsai M.-S.;Kuo Y.-H.;Chiu Y.-F.;Weng S.-H.;Su Y.-C.;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Kuo Y.-H.; Chiu Y.-F.; Weng S.-H.; Su Y.-C.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2
|
Jen-Chang Ko;Su Y.-J.;Lin S.-T.;Jhan J.-Y.;Ciou S.-C.;Cheng C.-M.;Chiu Y.-F.;Kuo Y.-H.;Tsai M.-S.;Lin Y.-W.; JEN-CHANG KO; Su Y.-J.; Lin S.-T.; Jhan J.-Y.; Ciou S.-C.; Cheng C.-M.; Chiu Y.-F.; Kuo Y.-H.; Tsai M.-S.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:36Z |
Up-regulation of extracellular signal-regulated kinase 1/2-dependent thymidylate synthase and thymidine phosphorylase contributes to cisplatin resistance in human non-small-cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Chiu Y.-F. ;Weng S.-H. ;Kuo Y.-H. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Chiu Y.-F.; Weng S.-H.; Kuo Y.-H.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:35Z |
Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells
|
Jen-Chang Ko ;Tsai M.-S. ;Weng S.-H. ;Kuo Y.-H. ;Chiu Y.-F. ;Lin Y.-W.; JEN-CHANG KO; Tsai M.-S.; Weng S.-H.; Kuo Y.-H.; Chiu Y.-F.; Lin Y.-W. |
| 臺大學術典藏 |
2021-03-11T07:58:24Z |
Cross-talk between SOX2 and TGFb signaling regulates EGFR-TKI tolerance and lung cancer dissemination
|
Kuo M.-H.; Lee A.-C.; Hsiao S.-H.; Lin S.-E.; Chiu Y.-F.; Yang L.-H.; Yu C.-C.; Chiou S.-H.; Huang H.-N.; JEN-CHANG KO; Chou Y.-T. |
| 臺大學術典藏 |
2021-03-11T04:30:21Z |
Genome-Wide Linkage Analysis of Lipids in Nondiabetic Chinese and Japanese From the SAPPHIRe Family Study
|
Hsiao C.-F.; Chiu Y.-F.; FU-TIEN CHIANG; Ho L.-T.; Lee W.-J.; Hung Y.-J.; Chen Y.-D.I.; Donlon T.A.; Jorgenson E.; Curb D.; Risch N.; Hsiung C.A. |
| 臺大學術典藏 |
2021-03-11T04:29:48Z |
Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study
|
Lee I.-T.; Chiu Y.-F.; Hwu C.-M.; He C.-T.; FU-TIEN CHIANG; Lin Y.-C.; Assimes T.; Curb J.D.; Sheu W.H.-H. |
| 臺大學術典藏 |
2021-03-05T06:07:31Z |
Differential expressions of cyclin D1 associated with better prognosis of cancers of ampulla of vater
|
MING-CHU CHANG; Chang Y.-T.; Sun C.-T.; Chiu Y.-F.; Lin J.-T.; Tien Y.-W. |
| 臺大學術典藏 |
2021-03-05T06:07:25Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang H.-J.; Lin Y.-L.; Wang H.-P.; Chiu Y.-F.; MING-CHU CHANG; Hsu C.-H.; Tien Y.-W.; Chen J.-S.; Hsieh R.-K.; Lin P.-W.; Shan Y.-S.; Cheng A.-L.; Chang J.-Y.; Whang-Peng J.; Hwang T.-L.; Chen L.-T. |
